Patra NeurosurgicalPatient education

Guide

Epilepsy surgery and devices

An overview of surgery and implanted devices for selected people whose seizures continue despite medicine. It explains who may be evaluated and how the treatments differ in what they aim to do.

How this page was written
Compiled from the sources cited on the page, with AI drafting assistance
Clinical review
Not individually reviewed by a clinician. How pages are written
Last updated
November 17, 2026

General information, not medical advice. In an emergency call 911. Full disclaimer

These treatments are for selected people with drug-resistant epilepsy. That means two well-chosen medicines, taken the right way, have not stopped the seizures. [1] Experts advise a referral to a specialized epilepsy center as soon as this is clear. A referral is not a promise of surgery. Most people who are referred do not have surgery. They still gain from the expert care. [2]

The first step is an epilepsy surgery evaluation. It looks for where seizures start. It also checks which treatments may be safe for you. [3]

If you see someone having a seizure, follow the CDC's seizure first aid steps. Call 911 if a seizure lasts longer than 5 minutes, if the person does not wake up, or if they are hurt. [4]

Main treatments

Other options: lesionectomy and other focal resections, vagus nerve stimulation, corpus callosotomy, and hemispherotomy. [7]

How the treatments compare

Each row comes from a different study. The people, the outcomes, and the time frames differ. So the rows cannot be compared exactly.

Treatment Main goal Who was studied Possible harms Follow-up
Temporal lobectomy [8] Seizure freedom 80 people with temporal lobe epilepsy in a trial 4 of 40 people (10 out of 100) had a side effect of surgery Clinic visits; no device
Laser ablation [9] Seizure freedom 551 people with temporal lobe epilepsy in 13 studies 17 out of 100 had a complication Clinic visits; no device
RNS [10] [5] Fewer seizures 191 adults in a trial; 256 adults followed up to 9 years Infection after about 4 out of 100 procedures Visits to set the device, review of brain data, new battery every few years
DBS [11] [12] Fewer seizures 110 adults in a trial, followed 5 years Serious device problems in 34 out of 100 by 5 years; more reports of low mood or memory problems Visits to set the device
Vagus nerve stimulation [13] Fewer seizures 439 adults and children in 5 trials Hoarse voice, cough, shortness of breath Visits to set the device
Corpus callosotomy [14] [15] Fewer drop seizures 1,644 people in 49 studies In children: repeat surgery for 7 out of 100; a disconnection syndrome in 14 out of 100 Clinic visits; no device

What the studies found. These are four different outcomes. Keep them apart.

Treatment Seizure freedom Fewer seizures Fewer drop seizures Quality of life
Temporal lobectomy [8] At 1 year, 58 out of 100 had no seizures that dim awareness, vs 8 out of 100 on medicine Fewer seizures that dim awareness Not reported Better than with medicine at 1 year
Laser ablation [9] 58 out of 100, pooled across studies Not reported Not reported Not reported
RNS [10] [5] 18 out of 100 had at least 1 seizure-free year during 9 years Seizures fell by a median of 75% at 9 years Not reported Improved and stayed improved
DBS [12] 16 out of 100 had at least 6 seizure-free months during 5 years Seizures fell by a median of 69% at 5 years Not reported Improved at 1 and 5 years
Vagus nerve stimulation [13] Not reported High settings were about 1.7 times as likely as low settings to cut seizures in half, over 12 to 20 weeks Not reported Small benefits; unclear
Corpus callosotomy [14] About 12 out of 100 Not reported Drop seizures stopped in about 62 out of 100 Not reported

A median is the middle value: half of people did better and half did worse.

About your medicines

RNS and DBS are approved as add-on treatments. They are used along with medicine. [16] [6] Do not stop or change an antiseizure medicine on your own. Any plan to change your medicine should come from your treating team.

Where to learn more

The International League Against Epilepsy keeps a list of expert papers on epilepsy surgery. [17] To find an epilepsy center, see the evaluation guide. It links to a list of centers.

Sources

  1. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-1077. Published June 1, 2010. Open source
  2. Jehi L, Jette N, Kwon CS, et al. Timing of referral to evaluate for epilepsy surgery: expert consensus recommendations from the Surgical Therapies Commission of the International League Against Epilepsy. Epilepsia. 2022;63(10):2491-2506. Published October 1, 2022. Open source
  3. Lado FA, Ahrens SM, Riker E, et al. Guidelines for specialized epilepsy centers: executive summary of the report of the National Association of Epilepsy Centers guideline panel. Neurology. 2024;102(4):e208087. Published February 1, 2024. Open source
  4. First Aid for Seizures. Centers for Disease Control and Prevention. Published May 15, 2024. Open source
  5. Nair DR, Laxer KD, Weber PB, et al. Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology. 2020;95(9):e1244-e1256. Published September 1, 2020. Open source
  6. Premarket Approval Supplement P960009/S219: Medtronic DBS Therapy for Epilepsy. US Food and Drug Administration. Published April 27, 2018. Open source
  7. Epilepsy and Seizures. National Institute of Neurological Disorders and Stroke. Published March 13, 2026. Open source
  8. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311-318. Published August 2, 2001. Open source
  9. Kerezoudis P, Parisi V, Marsh WR, et al. Surgical outcomes of laser interstitial thermal therapy for temporal lobe epilepsy: systematic review and meta-analysis. World Neurosurg. 2020;143:527-536.e3. Published November 1, 2020. Open source
  10. Morrell MJ; RNS System in Epilepsy Study Group. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology. 2011;77(13):1295-1304. Published September 1, 2011. Open source
  11. Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899-908. Published May 1, 2010. Open source
  12. Salanova V, Witt T, Worth R, et al. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology. 2015;84(10):1017-1025. Published March 1, 2015. Open source
  13. Panebianco M, Rigby A, Marson AG. Vagus nerve stimulation for focal seizures. Cochrane Database Syst Rev. 2022;7(7):CD002896. Published July 14, 2022. Open source
  14. Wu X, Ou S, Zhang H, et al. Long-term follow-up seizure outcomes after corpus callosotomy: a systematic review with meta-analysis. Brain Behav. 2023;13(4):e2964. Published April 1, 2023. Open source
  15. Ye VC, Mansouri A, Warsi NM, Ibrahim GM. Atonic seizures in children: a meta-analysis comparing corpus callosotomy to vagus nerve stimulation. Childs Nerv Syst. 2021;37(1):259-267. Published June 11, 2020. Open source
  16. Premarket Approval P100026: NeuroPace RNS System. US Food and Drug Administration. Published November 14, 2013. Open source
  17. Epilepsy Surgery. International League Against Epilepsy. Open source